![]() |
市場調查報告書
商品編碼
2009340
行動伽馬攝影機市場規模、佔有率、趨勢和預測:按產品、應用、最終用戶和地區分類,2026-2034年Mobile Gamma Cameras Market Size, Share, Trends and Forecast by Product, Application, End User, and Region, 2026-2034 |
||||||
2025年全球行動伽馬攝影機市場規模為5,970萬美元。展望未來,IMARC Group預測,該市場將在2026年至2034年間以3.26%的複合年成長率成長,到2034年達到8,040萬美元。目前,北美市場佔據主導地位,預計2025年市佔率將超過35%。推動北美市場成長的因素包括:醫療影像技術的進步、慢性病盛行率的上升、對攜帶式診斷設備需求的成長、腫瘤學和心臟病學領域應用範圍的擴大,以及政府的醫療保健支援措施。
行動式伽馬攝影機市場的發展主要受癌症和心血管疾病發生率上升的推動。這些設備需求量很大,因為它們攜帶式,可用於醫療中心的門診和重症監護室。此外,與傳統伽馬攝影機相比,它們具有更高的柔軟性,使其適用於各種臨床環境。
診斷成像技術的進步,例如空間解析度的提高以及診斷成像與數位系統的融合,發揮著至關重要的作用。此外,老年人口的不斷成長,以及老年人患有慢性疾病的高風險,也推動了對高效便捷的診斷方法的需求。
美國正崛起為行動式伽馬攝影機的主要市場。隨著癌症和心血管疾病等慢性病的盛行率上升,攜帶式伽馬攝影機的應用日益廣泛,因為這些疾病需要早期準確診斷才能進行有效治療。攜帶式伽瑪相機憑藉其移動性和易用性,可在包括門診和急診在內的各種醫療機構中使用。此外,人們日益認知到核醫學在診斷方面的潛力,以及高解析度和軟體整合等技術的進步,也是推動市場成長的因素。美國人口老化加劇了慢性病的發生率,這也進一步刺激了對移動式伽馬攝影機的需求。這項技術的特性使政府和醫療機構能夠專注於更具成本效益的診斷方法。政府主導的各項措施正在進一步加速先進醫學影像技術的發展,這對市場至關重要。
慢性病盛行率增加
慢性病日益普遍是推動該市場成長的主要因素。根據世界衛生組織(WHO)統計,非傳染性疾病(NCDs)每年導致4,100萬人死亡,佔全球死亡總數的74%。此外,癌症發生率的上升以及放射導引手術中對伽馬攝影機設備需求的顯著成長也推動了全球產品需求。世界衛生組織指出,癌症是全球主要死因之一,2020年約有1,000萬人死於癌症,約佔全球死亡總數的六分之一。因此,核子醫學掃描術診斷等醫學影像技術的不斷進步以及固態技術的出現對市場產生了積極影響。醫療設備小型化的趨勢是推動市場成長的另一個重要因素。此外,全球醫療保健支出的成長也促進了市場成長。推動攜帶式伽馬攝影機市場成長的其他因素包括:公眾可支配收入的增加、產品認知度的提高、醫療領域的顯著進步以及主要企業開展的大量研發活動。
技術進步
成像技術的進步已被證明在推動行動伽馬攝影機市場發展方面發揮著至關重要的作用。現代伽馬攝影機具有更高的解析度、便攜性和先進的資料處理能力,能夠產生精準的診斷影像。固體檢測器、高能量準直器和軟體整合等創新技術徹底革新了該領域,有望實現更高品質的影像和更快的診斷速度。所有這些都支持微創診斷技術的日益普及,尤其是在腫瘤學和心臟病學等領域,早期準確診斷至關重要。此外,整合的人工智慧 (AI) 和機器學習功能可實現即時影像分析,從而提高診斷準確性。醫療機構正擴大採用這項技術來提高營運效率,並應對與患者預後、誤診和工作流程管理相關的健康挑戰。隨著持續的研發投入以及先進成像技術在更多醫療機構的應用,這項技術仍然是支撐行動伽馬攝影機市場成長的基石。
向可攜式和即時護理解決方案過渡
醫療產業轉向攜帶式和即時診斷解決方案的轉變是推動行動伽馬攝影機市場發展的另一個關鍵因素。傳統的伽馬攝影機通常固定安裝,需要專用的成像室,這限制了其應用範圍。而移動式伽馬攝影機則具有柔軟性,可在病患床邊、門診甚至急診室進行診斷影像。這種移動性對於加護病房和行動不便的患者尤其重要。此外,降低醫療成本和提高營運效率的日益重視也加速了攜帶式影像解決方案的普及。移動式伽馬攝影機還能將先進的診斷能力帶到患者身邊,尤其是在農村和資源匱乏的地區,從而支持分散式醫療模式。無需大規模基礎設施即可進行即時診斷的能力符合當前的醫療保健趨勢,使得行動伽馬攝影機在已開發市場和開發中國家市場都越來越具有吸引力。
The global mobile gamma cameras market size was valued at USD 59.7 Million in 2025. Looking forward, IMARC Group estimates the market to reach USD 80.4 Million by 2034, exhibiting a CAGR of 3.26% from 2026-2034. North America currently dominates the market, holding a market share of over 35.0% in 2025. The advancements in medical imaging technology, rising prevalence of chronic diseases, increasing demand for portable diagnostic devices, growing adoption in oncology and cardiology applications, and supportive government healthcare initiatives are some of the factors driving the market in North America.
The market for mobile gamma cameras is supported by the growing incidence of cancer and cardiovascular disease. The increased demand for these devices is increasing as they are portable for use in an outpatient facility or a centralized site at the health care center. It is also more flexible than traditional gamma cameras for providing service in different clinical settings.
Improvements in imaging modalities have an important role, such as improvements in spatial resolution and integrating the imaging modalities with digital systems. Moreover, the increase in the elderly population, which is known as a high-risk group for developing chronic disease conditions, encourages the demand for efficient and simply available diagnostics.
The United States has emerged as a key region for mobile gamma cameras. The increasing prevalence of chronic diseases, such as cancer and cardiovascular disorders, that require an early and accurate diagnosis for better management, is increasing the use of portable gamma cameras. It will give them mobility and ease of handling to be used in different types of healthcare facilities, including outpatient and emergency departments. Another factor is the recognized potential of nuclear medicine with regard to diagnosis, alongside advances such as higher resolution and software integration. Moreover, the elderly population of the U.S. drives high demand for mobile gamma cameras due to their vulnerability to chronic diseases. The nature of the technology has made it possible for government and health service providers to focus on cost-effective diagnostic measures while further driving the pushes into advanced medical imaging technologies by government initiatives, which are essential boosts in the favor of the market.
Increasing prevalence of chronic diseases
The market is driven by the increasing prevalence of chronic diseases. According to the WHO, noncommunicable diseases (NCDs) are responsible for 41 Million deaths annually, accounting for 74% of all global fatalities. Besides this, the growing incidences of cancer and a considerable rise in the requirement for gamma camera devices during radio-guided surgery are driving the product demand on the global level. As per the WHO, cancer ranks among the leading causes of death globally, claiming approximately 10 Million lives in 2020, which is about 1 in every 6 deaths. In line with this, continual technological advancements in medical imaging options, such as nuclear imaging and the emergence of solid-state technology, are positively impacting the market. The growing trend of miniaturization of medical devices is acting as another significant growth-inducing factor for the market. The market is further driven by the increasing healthcare expenditure across the globe. Some of the other factors that are providing an impetus to the mobile gamma cameras market growth include the inflating disposable incomes of the masses, the rising product awareness, significant improvements in the healthcare sector and extensive research and development (R&D) activities conducted by key players.
Technological advancements
Advancements in imaging technology have proven to be instrumental in driving the market for mobile gamma cameras. Modern gamma cameras offer enhanced resolution, the ability to carry them from one point to another, and sophisticated data processing that helps produce precise diagnostic imaging. Innovative technologies like solid-state detectors, high-energy collimators, software integration have revolutionized the field with their promises of better image quality and rapid results. All of these things support the growing inclination toward minimally invasive diagnostic techniques, especially in oncology and cardiology, where early and accurate identification is imperative. Moreover, artificial intelligence and machine learning embedded into the system act as real-time interpreters of images to improve diagnosis accuracy. Healthcare service providers are increasingly embracing the technology to enhance operational efficiency and solve the health problems related to patient outcome improvement, diagnostic errors, and workflow management. With continued research and development efforts, technology remains the foundation for most growth within the mobile gamma cameras market as it takes advanced imaging technology to more healthcare option venues.
Shift toward portable and point-of-care solutions
The healthcare industry's shift toward portable and point-of-care diagnostic solutions is another key factor driving the mobile gamma cameras market. Traditional gamma cameras are often stationary and require dedicated imaging suites, limiting their accessibility. Mobile gamma cameras, however, offer flexibility, enabling imaging at the patient's bedside, in outpatient settings, or in emergency scenarios. This mobility is particularly valuable in critical care units and for patients with mobility constraints. Moreover, the growing emphasis on reducing healthcare costs and improving operational efficiency is accelerating the adoption of portable imaging solutions. Mobile gamma cameras also support decentralized healthcare models by bringing advanced diagnostic capabilities closer to patients, especially in rural or resource-limited settings. The ability to perform real-time diagnostics without extensive infrastructure requirements aligns with current healthcare trends, making mobile gamma cameras an increasingly attractive choice for both developed and developing markets.
Single-head mobile gamma cameras hold the largest mobile gamma cameras market share of 62.9% in 2025. This is due to their cost-effectiveness, versatility, and widespread adoption in various clinical applications. These systems are significantly less expensive than dual- or triple-head cameras, making them an economical choice for small to mid-sized healthcare facilities, especially in resource-constrained settings. The affordability of single-head units allows hospitals and diagnostic centers to invest in nuclear imaging technology without substantial capital expenditure. Moreover, single-head cameras are highly versatile, catering to a broad range of diagnostic needs, including thyroid scans, bone scintigraphy, renal imaging, and cardiac studies. Their portability and compact design make them ideal for point-of-care settings, enabling bedside imaging and use in outpatient clinics, emergency rooms, and rural healthcare centers.
Thyroid scanning dominates the market due to its critical role in diagnosing and monitoring thyroid disorders, which are increasingly prevalent worldwide. Conditions such as hypothyroidism, hyperthyroidism, thyroid nodules, and thyroid cancer necessitate accurate imaging for effective management. Mobile gamma cameras, equipped with advanced nuclear imaging capabilities, provide precise visualization of thyroid gland function and structure by detecting the uptake of radioactive isotopes like iodine-123 or technetium-99m. The portability of these cameras enhances accessibility, making thyroid scanning feasible in outpatient settings, rural areas, and point-of-care environments. This is particularly crucial as thyroid disorders are often underdiagnosed, especially in regions with limited healthcare infrastructure. Furthermore, the non-invasive and cost-effective nature of thyroid scans aligns with the increasing demand for affordable diagnostic solutions.
In 2025, hospitals hold the largest market share with 41.3% share due to their extensive infrastructure, large patient volume, and diverse diagnostic requirements. As primary centers for healthcare delivery, hospitals frequently manage complex and critical cases, including oncology, cardiology, and neurology, where gamma imaging is crucial for diagnosis, treatment planning, and monitoring. The availability of skilled professionals, such as nuclear medicine specialists and radiologists, further supports the widespread use of these devices in hospital settings. Moreover, hospitals often have greater financial capacity to invest in advanced diagnostic equipment like mobile gamma cameras.
In 2025 North America leads the market with 35.0% share. Some of the factors include advanced health care infrastructure, increased health care expenditure, and the speedy adoption of modern medical technologies. The well-established hospitals and diagnostic centers in the region are equipped with state-of-the-art imaging facilities to provide accurate treatment and diagnosis, hence creating a great need to acquire mobile gamma cameras. North America has the highest prevalence of chronic diseases, for instance, cancer and cardiovascular disorders, which compels the need for new advanced diagnostic tools like gamma cameras. The aging population of the region also necessitates the increased use of these portable imaging solutions for elderly patients who undergo frequent routine diagnostic assessments but may find it difficult to go to a hospital or facility.
UNITED STATES MOBILE GAMMA CAMERAS MARKET ANALYSIS
In 2025, the United States accounts for 83.9% of mobile gamma cameras market in North America. The market in the United States is driven by the increasing prevalence of chronic diseases, with an estimated 129 Million people affected by at least one major chronic condition, such as heart disease, cancer, diabetes, obesity, or hypertension, as defined by the US Department of Health and Human Services. This growing burden of disease has led to higher demand for advanced diagnostic imaging technologies. Mobile gamma cameras offer the flexibility to be used across various healthcare settings, including hospitals, clinics, and remote locations, improving access to diagnostic services for patients. Additionally, technological advancements in mobile gamma cameras, such as improved image resolution and faster scanning capabilities, are contributing to market growth. The push for cost-effective healthcare solutions further drives the adoption of mobile imaging systems, as they reduce the need for expensive fixed infrastructure. Favorable reimbursement policies for nuclear medicine procedures and the growing awareness of early disease detection and personalized treatment are also expected to support market expansion. Furthermore, the demand for mobile gamma cameras is anticipated to rise as early diagnosis and treatment of chronic conditions become increasingly prioritized in healthcare systems.
ASIA PACIFIC MOBILE GAMMA CAMERAS MARKET ANALYSIS
The mobile gamma cameras market in the Asia Pacific (APAC) region is experiencing growth due to the rising prevalence of chronic diseases and respiratory infections. According to PubMed Central, respiratory infections alone account for 475,000 deaths, representing 16.8% of total deaths in the region. Chronic conditions such as cancer, cardiovascular diseases, and diabetes are also on the rise, particularly in countries like China, India, and Japan. Mobile gamma cameras offer a vital solution, providing flexible diagnostic options in hospitals, outpatient clinics, and remote areas where healthcare access is limited. Government investments in healthcare infrastructure and increasing awareness of the benefits of early disease detection are expected to drive the demand for these mobile systems. Furthermore, advancements in technology, making mobile gamma cameras more affordable and efficient, contribute to their growing adoption across APAC.
EUROPE MOBILE GAMMA CAMERAS MARKET ANALYSIS
In Europe, the mobile gamma cameras market is growing due to the rising prevalence of chronic diseases, which are becoming more prominent in an aging population. As of January, 2023, the EU population was estimated at 448.8 Million, with more than one-fifth (21.3%) aged 65 years and over, according to Eurostat. This demographic shift is leading to an increase in age-related chronic conditions such as cancer, cardiovascular diseases, and neurological disorders, which drive the demand for advanced diagnostic tools. Mobile gamma cameras provide flexible solutions for hospitals, outpatient clinics, and remote healthcare facilities, especially in rural areas where access to fixed imaging infrastructure is limited. The ability to conduct imaging on-site offers cost-effective healthcare alternatives, which is particularly important in light of Europe's strained healthcare budgets. Moreover, advancements in technology, including improved image resolution and faster scanning capabilities, further boost market growth. With increasing government investments in healthcare infrastructure and the push for personalized medicine, mobile gamma cameras are becoming an essential tool in early disease detection and monitoring across the region.
LATIN AMERICA MOBILE GAMMA CAMERAS MARKET ANALYSIS
The mobile gamma cameras market in Latin America is expanding due to the increasing burden of chronic diseases, with Brazil estimating 928,000 deaths annually from chronic conditions such as heart disease, diabetes, and cancer, according to PubMed Central. This rising mortality rate drives the need for advanced diagnostic tools. Additionally, limited access to healthcare in rural areas creates demand for portable imaging solutions. Government efforts to improve healthcare infrastructure, along with the growing adoption of mobile health technologies, further support market growth. Mobile gamma cameras offer a cost-effective and accessible alternative for early disease detection in the region.
MIDDLE EAST AND AFRICA MOBILE GAMMA CAMERAS MARKET ANALYSIS
The mobile gamma cameras market in the Middle East and Africa is growing due to the increasing demand for advanced healthcare solutions, particularly in the UAE, Saudi Arabia, and South Africa. These regions have strong investments in healthcare infrastructure, and mobile gamma cameras offer a flexible and scalable solution to expand diagnostic services. For instance, according to the World Economic Forum, healthcare expenditure in the Gulf Cooperation Council (GCC) is predicted to reach USD 135.5 Billion by 2027. Mobile gamma cameras provide portable, cost-effective alternatives to traditional imaging methods, improving access to healthcare in remote areas. Government efforts to expand healthcare infrastructure further support market growth in the region.
Key players are focusing on developing innovative and advanced mobile gamma cameras to meet the growing demand for precision and portability in diagnostic imaging. They are incorporating features such as solid-state detectors, improved energy resolution, and artificial intelligence (AI)-powered imaging software to improve diagnostic efficiency and accuracy . Companies are also designing compact, lightweight, and user-friendly models to cater to point-of-care applications, ensuring wider adoption across diverse healthcare settings. These advancements allow market leaders to differentiate their products and appeal to a broader customer base. Moreover, collaborations with hospitals, research institutions, and nuclear medicine centers are enabling key players to expand their market presence and access new opportunities. Partnerships with technology providers help integrate cutting-edge software and data analytics capabilities into gamma camera systems. Additionally, collaborations with healthcare providers foster trust and brand loyalty, ensuring a steady demand for their products.